A recent report from the Congressional Research Service suggests that the Drug Enforcement Agency (DEA) is likely to approve a US Department of Health and Human Services recommendation to reschedule marijuana, which is currently a Schedule I drug. On the latest episode of Policy Outsider, Director of Operations and Fellow Heather Trela explains what such a change would mean for the marijuana industry and federal enforcement of the drug. The episode provides an overview of the drug scheduling system and its history, the challenges and limitations of rescheduling, and what comes next in the ever-changing marijuana policy landscape.
Guest:
Heather Trela, director of operations & fellow, Rockefeller Institute of Government
Learn More:
The High Court: How the Judiciary is Influencing Marijuana Policy
